GlassScriptPrepare for your visit
Larry D Stoppel
Optometrist · Lawrence, KS · NPI 1205807880
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$718.92
in general payments reported to CMS, 2019-2025 · $238 in 2025
The $238 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Who reported paying
General payments only, top 6 by amount.
- Bausch & Lomb Americas INC. $259.27
- Rxsight INC $122.53
- Abbvie INC. $116.75
- Allergan, INC. $67.19
- Maculogix, INC. $56.31
- Alcon Vision LLC $49.10
Drugs and devices associated with these payments
Miebo Vyzulta Lumigan Precision7 Infuse
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Larry Stoppel listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/236350/larry-d-stoppel